Kotaku Pok?mon World Championships Result In Unexpected Winner
     |
charlize theron barbra streisand barbra streisand hugh jackman Aly Raisman Oscar Results Jennifer Lawrence Fall
Tuesday, August 13, 2013
Kotaku Pok?mon World Championships Result In Unexpected Winner | Gawker Prank War Between Siblings Y
Sunday, August 11, 2013
Better Late Than Never: NPR Admits It Slandered South Dakota (Powerlineblog)
Apple Wins Patent-Infringement Case Against Samsung
Apple reportedly won its patent-infringement case against Samsung in a decision that limits the U.S. import of certain products.
According to Bloomberg, the U.S. International Trade Commission (USITC) in Washington today handed out an almost-final verdict in Cupertino's favor; the ban is still subject to review by President Barack Obama, who can overturn it on public policy grounds.
The news comes almost a year after Cupertino won more than $1 billion in a patent battle against Samsung.
A federal jury last year found two dozen Samsung devices infringed on patents already held by Apple, but aside from a hefty fine for Samsung, no other repercussions had been doled out. In fact, Judge Lucy Koh in December concluded that damages were enough for Apple, and a full ban of the products in question was not necessary.
But apparently $1.05 billion wasn't quite enough for the tech giant, and the company found itself back in court today, at the U.S. Court of Appeals for the Federal Circuit in Washington, for an injunction against Samsung.
The appeals court is not expected to rule on the case for several months, despite today's USITC announcement.
"Apple spent five years and $5 billion to develop a product and it was a revolutionary product," Apple lawyer William Lee told Bloomberg. "Samsung said, 'We can copy it easily.' They spent three months to bring the product to market."
But the South Korean company doesn't feel that it should take all the blame. A company lawyer told the court today that Apple needed to show "the difference between Samsung's infringement and Samsung's legitimate competition," Bloomberg reported.
The original ruling was based on a number of Apple design and utility patents with a variety of devices, including the Samsung Epic 4G, Capitivate, Galaxy S II, Indulge, Vibrant, and more.
This spring, a court ruling dropped more than $450 million in damages from the original $1.05 billion Apple won in August; the March 1 decision was based on the court's belief that some sales of the devices in question occurred before April 15, 2011 ? the date Apple sued Samsung.
Cupertino quickly requested that the judge reinstate more than $85 million in damages ? $40,494,356 for the Galaxy S II and $44,792,974 for the Infuse 4G.
What seems like a never-ending dispute between the two phone makers continued in May, when Apple revealed that it wanted to add the Galaxy S 4 to the list of 22 infringing Samsung devices. Cupertino kindly offered to drop one of the gadgets already on the list and swap in Samsung's newest flagship Android smartphone.
As the case continues, both sides have continued to update their lawsuits each time they release a new product. Last year, Apple added the Galaxy S III, while Samsung then took aim at the iPhone 5.
Neither Apple nor Samsung immediately responded to PCMag's request for comment.
Source: http://feeds.ziffdavis.com/~r/ziffdavis/pcmag/breakingnews/~3/8tjPZaaZHA4/0,2817,2422936,00.asp
dwight howard mariah carey djokovic djokovic josh smith Andre Iguodala Ernesto Arguello
Saturday, August 10, 2013
Ivanhoe Energy responds to recent trading activity
Ivanhoe Energy Inc. (TSX: IE; NASDAQ: IVAN) announced that it knows of no reason for the decrease in the Company's share price late in the trading session on August 8, 2013. There have been no material adverse developments or circumstances with respect to the Company's activities that would explain this sudden drop.
The Ivanhoe Energy executive management team is committed to the Company's success and remains optimistic that 2013 and 2014 will see significant progress in its priority areas.
This article is for information and discussion purposes only and does not form a recommendation to invest or otherwise. The value of an investment may fall. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser. More
Related Companies
Source: http://feeds.oilvoice.com/~r/NorthAmericaHeadlines/~3/_mA6G8rLsow/821d54c5ec39.aspx
magic mike trailer Alan Turing brave Stephanie Rice Meet the Pyro Karen Klein Colorado fires
Alexandra Daddario Shows Off Vulnerable Side In 'Percy Jackson: Sea Of Monsters'
'You sort of find out where she comes from and who she was,' actress tells MTV News of her warrior demigod.
By Amy Wilkinson
Source: http://www.mtv.com/news/articles/1712076/alexandra-daddario-percy-jackson-sea-of-monsters.jhtml
vontaze burfict jimmy kimmel amzn white house correspondents dinner phoenix coyotes bruce irvin charlie st cloud
Thursday, August 8, 2013
Watch Me Do Something Impossible In Three Totally Easy Steps
Here's what the Swedish artist Oscar Reutersvard did. In 1934, he got himself a pen and paper and drew four cubes, like this.
Then he drew some more, like this.
And, then ? and this is where he got mischievous ? he drew one more set, like this.
He called this final version "Impossible Triangle of Opus 1 No. 293aa." I don't know what the "293aa" is about, but he was right about "impossible." An arrangement like this cannot take place in the physical universe as we know it.
You follow the bottom row along with your eyes, then add another row, but when the third row pops in, where are you?
Nowhere you have ever been before. At some step in the process you've been tricked, but it's very, very hard to say where the trick is, because what's happening is your brain wants to see all these boxes as units of a single triangle and while the parts simply won't gel, your brain insists on seeing them as a whole. It's YOU whose playing the trick, and you can't un-be you. So you are your own prisoner.
At first, this feels like a neurological trap, like a lie you can't not believe.
But when you think about for a bit, it's the opposite, it's a release. Twenty years later, the mathematician/physicist Roger Penrose (and his dad, psychologist Lionel Penrose) did it again. They hadn't seen Reutersvard's triangle. Theirs was drawn in perspective, which makes it even more challenging. Here's my version of their Penrose Triangle.
What's cool about this? I'm going to paraphrase science writer John D. Barrow, who has written about these triangles in several places: We know that these drawings can't exist in the physical world. Even as we look at them, particularly when we look at them, we know they are impossible. And yet, we can imagine them anyway. Our brains, it turns out, are not prisoners of the world we live in; we can fly free! We can, any time we like, create the impossible.
These triangles prove it. We don't feel crazy when we look at them, we laugh. We sense we've just stolen something or seen something that can't be out there in the world, and yet, here it is! As John Barrow puts it:
The impossible is not necessarily something that lies outside our mental experience even if it falls outside our physical experience. We can create mental worlds which are quite different from the one we experience.
You find versions of "impossible triangles" in M.C. Escher's drawings, of course, but variants turn up in Lewis Carroll's Alice in Wonderland stories, in Jorge Luis Borges, in Breugel, in Magritte. We may be the only creatures on Earth that can break the rules this way. One of the most wonderful thing about the human mind, I think, is it can contradict itself, like this:
John D. Barrow has written about impossible triangles in his 1999 book Impossibility: The Limits of Science and the Science of Limits. He's also included some in his picture book Cosmic Imagery: Key Images in the History of Science. He's a professor of mathematical sciences and director of the Millennium Mathematics Project at Cambridge University.
nfl draft grades Jon Jones Broken Toe matt barkley russell westbrook NFL Draft Grades 2013 living social pnc
Thursday, August 1, 2013
Facebook looks set to open at IPO price a year after debut
markets 
19 hours ago
KAREN BLEIER / AFP - Getty Images
This February 25, 2013 photo taken in Washington, DC, shows the splash page for the Internet social media giant Facebook.
More than a year after their rocky debut, Facebook shares traded above their $38 initial public offering price in early trading Wednesday.
Why are the shares taking off?
1. Mobile Games Publishing, a program Facebook announced Monday that will help small and midsize developers distribute their games.
Though just a pilot program, Mobile Games illustrates steps Facebook is taking to generate revenue from areas outside advertising. Taking a cut of partners' gaming revenue, the company will deliver targeted ads, analytics tools and the ability to work with Facebook's gaming department.
In its blog announcing the news, Facebook said, "We are invested in the success of these games, and in exchange for a revenue share, we will be collaborating deeply with developers in our program by helping them attract high-quality long-term players for their games. We'll also be sharing analytics tools and the expertise we've gained from helping games grow on our platform for more than six years."
2. Earnings results weren't just better than expected but show Facebook executing in all the major areas about which Wall Street has been nervous. Revenue growth is accelerating, and the company is generating more money from its mobile users than expected. It also disclosed some impressive numbers on its ad campaigns' return-on-investment.
Perhaps most important, CEO Mark Zuckerberg didn't hesitate to address widespread concerns.
(Read more: Facebook earnings beat; shares jump 20%)
And investors took note of the fact that Facebook's upside surprise stands in sharp contrast to Google's disappointing results, indicating that the former's social and mobile ads are gaining more traction.
3. Analysts have been speculating that Facebook will be added to the S&P 500 index within the next year, which would significantly broaden the company's investor base.
CNBC media and entertainment reporter Julia Boorstin contributed to this report.
London Olympics Kristen Stewart Rupert Sanders Photos 2016 Olympics TD Bank mountain lion hanley ramirez Christian Bale visits victims
UPCI researchers target 'cell sleep' to lower chances of cancer recurrence
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 1-Aug-2013[ | E-mail |
Share ] Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences
PITTSBURGH, Aug. 1, 2013 An international research team led by University of Pittsburgh Cancer Institute (UPCI) scientists discovered that by preventing cancer cells from entering a state of cellular sleep, cancer drugs are more effective, and there is a lower chance of cancer recurrence. The findings, which will be published in the August 15 issue of the journal Cancer Research and are available online, are the first to show that it is possible to therapeutically target cancer cells to keep them from entering a cellular state called quiescence, or "cell sleep." Quiescence can be a dangerous source of tumor recurrence because cancer drugs don't typically destroy quiescent cells.
"Successful cancer therapy often is hampered by tumor cell quiescence because these cells remain viable and are a reservoir for tumor progression," said Anette Duensing, M.D., assistant professor of pathology at UPCI. "By inhibiting a key regulator of quiescence, we are able to kill a larger fraction of cancer cells."
Dr. Duensing and her colleagues made the discovery while studying gastrointestinal stromal tumors (GISTs), which are uncommon tumors that begin in the walls of the gastrointestinal tract. According to the American Cancer Society, about 5,000 cases of GISTs occur each year in the United States with an estimated five-year survival rate of 45 percent in patients with advanced disease.
GISTs are caused by a single gene mutation, which means they can be successfully treated with the targeted therapy drug imatinib, known by the trade name Gleevec. Unlike traditional chemotherapy, which kills all rapidly dividing cells, targeted therapy stops cancer by interfering with specific molecules needed for tumor growth.
Unfortunately, GISTs rapidly develop resistance to the treatment and complete cancer remission using Gleevec is rare. A key regulator of the cancer cell sleep process is a protein complex called DREAM, which is named for the multiple proteins involved. Gleevec induces cell sleep using the DREAM complex, which means that the drug intrinsically limits its own effectiveness.
"When we disrupted the DREAM complex in the lab, we significantly increased cancer cell death using Gleevec," said Dr. Duensing. "This underscores the importance of the DREAM complex as a novel drug target worthy of preclinical and clinical investigations."
###
The study is a collaboration with the Dana-Farber Cancer Institute in Boston and the Catholic University in Leuven, Belgium. Additional co-authors of this study include Sergei Boichuk, M.D., Ph.D., Joshua A. Parry, B.S., Kathleen R. Makielski, M.S., Julianne L. Baron, B.S., James P. Zewe, B.S., Keith R. Mehalek, M.S., and Danushka S. Seneviratne, B.S., all of UPCI's Cancer Virology Program; James A. DeCaprio, M.D., and Larisa Litovchick, Ph.D., both of the Dana-Farber Cancer Institute; Patrick Schffski, M.D., M.P.H., Maria Debiec-Rychter, M.D., Ph.D., and Agnieszka Wozniak, Ph.D., all of the Catholic University of Leuven in Belgium; and Nina Korzeniewski, Ph.D., of the University of Heidelberg School of Medicine in Germany.
This research was supported by Research Scholar Grant RSG-08-092-01-CCG from the American Cancer Society, the GIST Cancer Research Fund, The Life Raft Group and a number of private donations.
About UPCI
As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. UPCI, a partner with UPMC CancerCenter, investigators are world-renowned for their work in clinical and basic cancer research.
http://www.upmc.com/media
Contact: Allison Hydzik
Phone: 412-647-9975
E-mail: HydzikAM@upmc.edu
Contact: Jennifer Yates
Phone: 412-647-9966
E-mail: YatesJC@upmc.edu
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 1-Aug-2013[ | E-mail |
Share ] Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences
PITTSBURGH, Aug. 1, 2013 An international research team led by University of Pittsburgh Cancer Institute (UPCI) scientists discovered that by preventing cancer cells from entering a state of cellular sleep, cancer drugs are more effective, and there is a lower chance of cancer recurrence. The findings, which will be published in the August 15 issue of the journal Cancer Research and are available online, are the first to show that it is possible to therapeutically target cancer cells to keep them from entering a cellular state called quiescence, or "cell sleep." Quiescence can be a dangerous source of tumor recurrence because cancer drugs don't typically destroy quiescent cells.
"Successful cancer therapy often is hampered by tumor cell quiescence because these cells remain viable and are a reservoir for tumor progression," said Anette Duensing, M.D., assistant professor of pathology at UPCI. "By inhibiting a key regulator of quiescence, we are able to kill a larger fraction of cancer cells."
Dr. Duensing and her colleagues made the discovery while studying gastrointestinal stromal tumors (GISTs), which are uncommon tumors that begin in the walls of the gastrointestinal tract. According to the American Cancer Society, about 5,000 cases of GISTs occur each year in the United States with an estimated five-year survival rate of 45 percent in patients with advanced disease.
GISTs are caused by a single gene mutation, which means they can be successfully treated with the targeted therapy drug imatinib, known by the trade name Gleevec. Unlike traditional chemotherapy, which kills all rapidly dividing cells, targeted therapy stops cancer by interfering with specific molecules needed for tumor growth.
Unfortunately, GISTs rapidly develop resistance to the treatment and complete cancer remission using Gleevec is rare. A key regulator of the cancer cell sleep process is a protein complex called DREAM, which is named for the multiple proteins involved. Gleevec induces cell sleep using the DREAM complex, which means that the drug intrinsically limits its own effectiveness.
"When we disrupted the DREAM complex in the lab, we significantly increased cancer cell death using Gleevec," said Dr. Duensing. "This underscores the importance of the DREAM complex as a novel drug target worthy of preclinical and clinical investigations."
###
The study is a collaboration with the Dana-Farber Cancer Institute in Boston and the Catholic University in Leuven, Belgium. Additional co-authors of this study include Sergei Boichuk, M.D., Ph.D., Joshua A. Parry, B.S., Kathleen R. Makielski, M.S., Julianne L. Baron, B.S., James P. Zewe, B.S., Keith R. Mehalek, M.S., and Danushka S. Seneviratne, B.S., all of UPCI's Cancer Virology Program; James A. DeCaprio, M.D., and Larisa Litovchick, Ph.D., both of the Dana-Farber Cancer Institute; Patrick Schffski, M.D., M.P.H., Maria Debiec-Rychter, M.D., Ph.D., and Agnieszka Wozniak, Ph.D., all of the Catholic University of Leuven in Belgium; and Nina Korzeniewski, Ph.D., of the University of Heidelberg School of Medicine in Germany.
This research was supported by Research Scholar Grant RSG-08-092-01-CCG from the American Cancer Society, the GIST Cancer Research Fund, The Life Raft Group and a number of private donations.
About UPCI
As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. UPCI, a partner with UPMC CancerCenter, investigators are world-renowned for their work in clinical and basic cancer research.
http://www.upmc.com/media
Contact: Allison Hydzik
Phone: 412-647-9975
E-mail: HydzikAM@upmc.edu
Contact: Jennifer Yates
Phone: 412-647-9966
E-mail: YatesJC@upmc.edu
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2013-08/uops-urt080113.php
magic mike trailer Alan Turing brave Stephanie Rice Meet the Pyro Karen Klein Colorado fires
Canada, we should be ashamed for turning our back on veterans
Report an error
More Coverage
Related Stories
Related Videos
This should not be how a grateful nation says thank you.
Buried deep within the detail of the City of Toronto?s 2013 interim report on homelessness is a single startling fact.
Around 16% of those living rough on the streets of Canada?s biggest city said they had served in the Canadian military.
That?s right. Almost one in five self-identify as military veterans yet they make their home on the sidewalk or under a bridge.
This is something that should shock all Canadians.
Nobody is forced to serve in our all-volunteer navy, army and air force. People choose to don our military uniform and prepare to defend Canada from her enemies at home and abroad at considerable personal sacrifice.
Be it in the skies over Libya or the mountains of Afghanistan, in recent years more and more military personnel have gone into harm?s way for Canada and freedom.
Then there are those who also stand and serve without leaving the country but are essential none the less.
The findings of the Toronto survey roughly align with a study released two weeks ago by Western University in London, Ont.
It found that Canadian Forces veterans, who at one time served and protected their country, are now facing one of the toughest battles of their lives ? homelessness.
A national study by assistant nursing professor Susan Ray and nursing professor Cheryl Forchuk, the first of its kind on Canada?s homeless veterans, identified this new trend of homeless ex-military personnel.
Prior research on the subject, which has primarily originated in the United States, presents the scenario of homeless veterans having seen overseas deployment, witnessing trauma, having Post Traumatic Stress Disorder (PTSD) and not being able to adjust when they get home.
Research with Canadian homeless veterans shows a whole different number of causes ? the primary one being alcohol abuse ? but it is a growing problem all the same.
?For a lot of them it was from drinking, which started in the military, escalated over time and 10 years later you would see the alcoholism, and through that they would lose their job, their relationships, their housing,? Prof. Ray says.
Perhaps the single biggest challenge for vets is making the successful transition from military to civilian life and that remains a large factor in the veterans? homelessness.
A spokesman for Julian Fantino, the Minister of Veterans Affairs, told the Toronto Sun that in 2012 Ottawa launched a national pilot project reaching out to former servicemen and women who are homeless or at risk of homelessness.
?Canadian veterans are entitled to thousands of dollars worth of benefits and services that are not available to the general public, which makes even one case of a homeless veteran deeply unfortunate and unnecessary,? he said.
The spokesman urged anyone who is aware of a vet living on the streets to contact 1-866-522-2122 (English) or 1-866-522-2022 (French) so that emergency funding and a certified case manager can be assigned.
Which shows that the federal minister is aware of the problem, however waiting for those in need to ask for help may not be the best way forward.
Too many of the homeless live on the margins of society and remain unaware of how close help can be.
Plenty speak about the difficulty in adjusting to an unstructured civilian life and the lack of supports at all levels they received BEFORE moving from military to civilian life.
No matter the reason or the causes, the fact that increasing numbers of our former military personnel face a life of homeless desperation should shame us all.
Poll
Does Canada treat its veterans well?
Source: http://www.torontosun.com/2013/07/31/canada-we-should-be-ashamed-for-turning-our-back-on-veterans
Barkevious Mingo nfl draft 2013 NFL draft NFL.com Rebecca Martinson EJ Manuel Dion Jordan
BBC tops best science news site list
30 July 2013
Last updated at 06:49 ET
The BBC has topped a list of the 10 best websites for science news.
The BBC News science and environment page beat off tough competition such as New Scientist and National Geographic in the list compiled by the website RealClearScience.
The BBC's journalists were commended for an "ability to communicate complex topics to a global audience".
Nature News came just behind the BBC in the top 10 and Wired's science coverage was listed at number three.
RealClearScience also said the BBC's science team had "extraordinary journalistic instinct".
On Nature News, which came at number two in the list, the site said "the reliability and readability of the information found here proves that Nature takes its commitment to journalism every bit as seriously as it does its commitment to groundbreaking research".
Wired's science coverage took third place, with the magazine being praised for being "at the forefront of all things science and technology". Its reporters Brandon Keim and Nadia Drake were also described as "top-notch".
The other science news sites commended by RealClearScience, in descending order, were: Ars Technica, New Scientist, Popular Science, Live Science, National Geographic, Smithsonian Magazine and io9.
US National Public Radio's science section, the relatively new magazine Nautilus and Slate received honourable mentions.
Source: http://www.bbc.co.uk/news/science-environment-23503694#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa
bars lindzi cox bachelor finale courtney robertson ben flajnik hunger games premiere red meat
Subscribe to:
Posts (Atom)